Infectious & parasitic topics

Enteromyxosis in gilthead sea bream: intestinal injury, wasting and farm control

Enteromyxum leei causes enteromyxosis, an intestinal disease that can produce poor feeding, weight loss, impaired growth and mortality in gilthead sea bream. The parasite damages the intestinal barrier and can spread between fish. Wasting alone is not diagnostic. Seek confirmation and assess stock separation and welfare; nutritional supplements or antibiotics should not be advertised as an established parasite cure.

Updated 910 words · 5 min read6 sources · scope listed below
A live gilthead sea bream swimming in clear water off Sardinia

This photograph shows a live gilthead sea bream swimming in its natural marine setting. It provides species context only; no disease signs are identified. Credit and license details are linked below.

SardinianFish.jpg · Roberto Pillon · CC BY 2.0 · Full credit & reuse terms

Reading the sources

This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.

A damaged intestine cannot use feed normally

E. leei develops among cells of the intestinal lining. The resulting inflammation and disrupted barrier interfere with normal gut function. Primary research has demonstrated impaired barrier integrity in infected sea bream, helping explain why the problem is more than simply insufficient food offered.

Affected fish may both eat less and make poorer use of what they consume. Increasing the ration can therefore waste feed and burden water quality without restoring growth. The clinical aim is to establish why the gut is failing and prevent further disease, while maintaining a suitable diet and environment for fish still able to feed.

Source: Disruption of gut integrity and permeability contributes to enteritis; Gilthead seabream intestinal transcriptome and microbiota upon Enteromyxum leei infection; Introduction to fish health management.

Recognize progressive wasting before all fish look affected

Poor growth, reduced appetite and declining body condition can develop across an affected group. Advanced fish may become markedly emaciated. The distribution can be uneven, so an average sample weight can hide a vulnerable fraction of the stock.

These signs overlap inadequate feeding, other intestinal parasites and chronic systemic disease. Enterospora nucleophila is an important distinct parasite associated with emaciation in sea bream; the name enteromyxosis should not be applied to every thin fish. Increasing losses or fish unable to maintain normal activity deserve prompt fish-health assessment.

Source: Fish farmer’s guide to parasitic infections in sea bass and sea bream; Disruption of gut integrity and permeability contributes to enteritis; Introduction to fish health management.

Diagnosis connects parasite identity to intestinal disease

A diagnostic service can combine examination of intestinal tissues with appropriate parasite tests. Histopathology helps show the lesion and its distribution; targeted detection helps establish identity. Either result needs interpretation alongside host species and clinical findings.

A negative check from one convenient fish is not a health certificate for the cage. Disease stage and tissue distribution influence detection, and concurrent conditions may contribute to wasting. Arrange sampling with the fish-health professional rather than attempting intestinal procedures. The most useful conclusion explains whether the identified parasite plausibly accounts for the group’s declining condition.

Source: Fish farmer’s guide to parasitic infections in sea bass and sea bream; Disruption of gut integrity and permeability contributes to enteritis; Introduction to fish health management.

Direct spread makes connected stock a practical concern

Unlike a simple assumption that every myxozoan requires an identified invertebrate host between successive fish infections, E. leei can transmit directly between fish. Shared water and infected material therefore matter to stock separation and movement decisions.

Avoid moving suspect fish into unaffected units on the basis of external appearance. Separation should account for water connections, handling equipment and the practical flow of work. A cage or tank label does not create a biological barrier if contaminated water or material moves freely between groups. Discuss the scope of exposed stock with the attending health team.

Source: Fish farmer’s guide to parasitic infections in sea bass and sea bream; Fish health management considerations in recirculating aquaculture systems: pathogens.

What care can and cannot currently accomplish

There is no established routine curative treatment that should be promised to a producer. Antibiotics do not directly eliminate this myxozoan. Treatment of a confirmed concurrent bacterial problem is a separate veterinary decision with food-fish authorization requirements.

Maintain suitable water conditions and a diet the fish can actually use. Avoid repeated handling and unsupported temperature or salinity experiments on already compromised stock. Severely wasted fish that cannot feed or swim normally need a welfare plan. A reduction in visible losses should be assessed together with body condition and growth, because survivors can remain clinically important.

Source: Gilthead seabream intestinal transcriptome and microbiota upon Enteromyxum leei infection; Fish farmer’s guide to parasitic infections in sea bass and sea bream; Aquaculture and aquaculture drugs basics; Introduction to fish health management.

Microbiome findings are research leads, not a product prescription

A 2025 study found changes in intestinal bacteria and host gene activity during E. leei infection. This supports a close relationship between the parasite, the host and the gut community. It does not establish that a particular probiotic, feed additive or commercial microbiome test prevents or cures enteromyxosis.

Evaluate claimed solutions against demonstrated outcomes in the relevant fish and production setting. An immune marker or changed bacterial profile is not the same as restored growth, reduced disease or elimination of infection. Prevention still depends on stock health, exposure assessment and practical separation rather than an unvalidated feed claim.

Source: Gilthead seabream intestinal transcriptome and microbiota upon Enteromyxum leei infection; Disruption of gut integrity and permeability contributes to enteritis; Fish farmer’s guide to parasitic infections in sea bass and sea bream.

Practical questions

Is this just starvation?

No. Reduced intake may occur, but intestinal injury can also impair nutrient use.

Can antibiotics cure it?

They do not directly treat the myxozoan; a concurrent bacterial infection is a separate question.

Can apparently normal fish be moved safely?

External appearance alone does not establish freedom from infection. Obtain a risk assessment before movement.

Related animal-health reading

Cite this reference

LivestockDefense. “Enteromyxosis in gilthead sea bream: intestinal injury, wasting and farm control.” Updated 2026-11-02. https://livestockdefense.com/threats/sea-bream-enteromyxosis-from-enteromyxum-leei/

Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.

How to cite a page and its revision ↗

Sources & boundaries

Read the evidence in context.

These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.

  1. U.S. Food and Drug Administration: Aquaculture and Aquaculture Drugs Basics

    Source update: Not provided. Most recent check: 2026-10-29.

    FDA approves final drug products and intended uses, not active ingredients alone; no treatment authorization, drug choice or dosage inferred from a laboratory result.

  2. University of Florida IFAS Extension: Introduction to fish health management

    Source update: Not provided. Most recent check: 2026-11-02.

    Clinical/environmental differential assessment, skin injury and early professional diagnosis; no laboratory or chemical-treatment procedures.

  3. University of Florida IFAS Extension: Fish health management considerations in recirculating aquaculture systems: pathogens

    Source update: Not provided. Most recent check: 2026-11-02.

    Shared-water/equipment pathogen amplification and biofilter-sensitive treatment context; no disinfectant or pathogen-handling procedure.

  4. Parasites & Vectors / primary pathology research: Disruption of gut integrity and permeability contributes to enteritis

    Source update: 2019. Most recent check: 2026-11-02.

    Abstract for intestinal barrier dysfunction, anorexia and wasting; no experimental infection or tissue procedures.

  5. Animal Microbiome / primary research: Gilthead seabream intestinal transcriptome and microbiota upon Enteromyxum leei infection

    Source update: 2025. Most recent check: 2026-11-02.

    Abstract for inflammation, poor conversion and host/microbiota interaction; no probiotic efficacy or validated farm biomarker claim.

  6. ParaFishControl / EU-funded fish-health research consortium: Fish farmer’s guide to parasitic infections in sea bass and sea bream

    Source update: 2020. Most recent check: 2026-11-02.

    Indexed enteromyxosis clinical, fish-to-fish transmission and diagnosis/control sections; no experimental transmission, chemical or parasite-handling procedures.

Full source register ↗